Reuschenbach, Miriam
Stephan, Anna-Janina
Saxena, Kunal
Prabhu, Vimalanand S.
Jacob, Christian
Schneider, Kim Maren
Greiner, Wolfgang
Wölle, Regine
Hampl, Monika
Funding for this research was provided by:
Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
Article History
Received: 31 January 2022
Accepted: 21 March 2022
First Online: 14 April 2022
Declarations
:
: VP and KS are full-time employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. MR and RW are full-time employees of MSD Sharp & Dohme GmbH. AJS was a full-time employee of MSD Sharp & Dohme GmbH at the time of study execution. KMS and CJ are full-time employees of Xcenda GmbH, acting as contractors of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA for the execution of this study and the writing of the manuscript. WG received personal fees from Xcenda GmbH during the conduct of the study. MH received honoraria as speaker and member of medical advisory boards from MSD Sharp & Dohme GmbH.
: This study used anonymized German claims data. Therefore, no ethics approval was needed by an independent ethics committee or institutional review board. The utilized database addresses all data protection regulations in Germany.
: For this type of study, formal consent is not required.
: Not applicable.